Tecsys Reports Record Q1 Performance with Strong Revenue and EBITDA Growth
Tecsys Inc. (TSE:TCS) reported record first-quarter revenue of C$50 million, a 9% increase year over year, driven by strong performance in its healthcare sector. Adjusted EBITDA more than doubled to C$6.9 million and net profit surged 306% to C$3.1 million. The company attributed the growth primarily to expansions among existing customers like Prisma Health and UT Southwestern Medical Center. Tecsys also raised its fiscal 2027 guidance, increasing expected growth ranges for Elite SaaS revenue and overall sales while lifting adjusted EBITDA margin forecasts to between 11% and 14%. The company's remaining performance obligations exceeded C$250 million at the end of Q1. CEO Peter Brereton highlighted that over 90% of pipeline activity is now split evenly between new accounts and existing customer expansions, with migrations becoming a smaller component. SaaS revenue grew by 18%, while Elite SaaS revenue rose 24%. Tecsys' total annual recurring revenue reached C$93.7 million at quarter-end, up from C$19.1 million in the prior-year period.
Tickers: $TCYSF
Topics: ebitda_increase net_profit_rise revenue_growth saaS_expansion